What does positive surgical margins mean for Non-Small Cell Lung Cancer
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Positive Surgical Margins in NSCLC
What Are Surgical Margins?
When a surgeon removes a lung cancer tumor, they don't just take out the visible cancer—they also remove some surrounding healthy lung tissue around it. This border of healthy tissue is called the surgical margin. Think of it like cutting out a stain from fabric; you want to remove not just the stain itself, but some clean fabric around it to make sure you got it all.
What "Positive" Margins Mean
A positive margin means that cancer cells were found at the edge of the tissue that was removed. In other words, the surgeon didn't remove enough tissue around the tumor, and cancer cells may have been left behind in your body. This is also called an R1 resection (R1 = microscopic residual disease—cancer cells too small to see with the naked eye but detected under a microscope).
For comparison:
- R0 (negative margins) = No cancer cells at the edges ✓ (the goal)
- R1 (positive margins) = Cancer cells found at the edges ⚠️
- R2 (gross residual disease) = Visible cancer left behind
Why Margins Matter for NSCLC
According to the NCCN Guidelines for Non-Small Cell Lung Cancer, margin status is a critical factor in determining outcomes:
For early-stage disease (Stage I/II): Patients treated with surgery alone had better recurrence rates and overall survival with negative margins compared to positive margins.
The clinical reasoning: Positive margins suggest that cancer cells may still be present in the lung tissue, which increases the risk that:
- The cancer could grow back locally (in the same area)
- The disease may progress more aggressively
- Additional treatment may be needed
What Happens After Positive Margins Are Found
If your pathology report shows positive margins, your oncology team typically considers:
- Adjuvant (post-surgery) chemotherapy - Systemic therapy to target any remaining cancer cells throughout the body
- Radiation therapy - Targeted radiation to the surgical area to eliminate any remaining local disease
- Close monitoring - More frequent imaging and follow-up appointments to catch any recurrence early
According to NCCN Guidelines, patients with clinical stage IB or greater, or those with high-risk features (which would include positive margins), should be referred to medical oncology for evaluation to determine the best additional treatment approach.
Important Questions to Ask Your Care Team
If your pathology report mentions positive margins, these questions can help you understand your specific situation:
- Which margin was positive? (The location matters—margins near certain structures may have different implications)
- How close were the cancer cells to the edge? (This helps determine how aggressive follow-up treatment needs to be)
- What additional treatment do you recommend for my specific case? (Chemotherapy, radiation, or both?)
- Could re-resection be an option? (Sometimes a second surgery to remove more tissue is possible)
- What surveillance plan will we follow? (How often will I have imaging and follow-up visits?)
The Bottom Line
Positive surgical margins indicate that complete tumor removal may not have been achieved, which increases the risk of cancer recurrence. However, this doesn't mean your cancer is incurable—it means your treatment plan will likely need to include additional therapies beyond surgery alone. Your multidisciplinary team (surgeon, medical oncologist, and radiation oncologist) will work together to determine the best approach for your individual situation.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Non-Small Cell Lung Cancer (2026)Browse all NCCN Guidelines for Patients →Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
What is the survival rate for advanced NSCLC
I appreciate this important question. However, I need to be honest about what I can and cannot tell you based on the available evidence. What the Gu
What is the survival rate for advanced NSCLC non-small cell lung cancer
I appreciate this important question. However, I need to be direct with you: I cannot and should not provide you with a specific survival rate number,